BiotechTube
Home/Lohocla Research/Boris Tabakoff, PhD
BT

Boris Tabakoff, PhD

Founder, Chief Executive Officer, Chief Scientific Officer

Lohocla Research

Therapeutic Areas

Chronic PainNeuroinflammationAddictionAlcohol Use Disorder (AUD)Substance Use Disorders (SUD)

Lohocla Research Pipeline

DrugIndicationPhase
Multi-target Chronic Pain TherapeuticChronic Pain / NeuroinflammationPreclinical
Multi-target Addiction TherapeuticAlcohol Use Disorder / Substance Use DisordersPreclinical

Leadership Team at Lohocla Research

PH
Paula Hoffman, PhD
Vice President for Research and Development
View full Lohocla Research profile